Delivery Order SPE2DB20D1004-SPE2DB24FF0H6
Award Date
12/12/23
Potential Completion Date
12/13/23
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xeljanz XR 11 mg tablets. The $14,120.37 firm fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Xeljanz XR 11 mg tablets to the agency. The contract is a delivery order valued at $1,507.35, with a completion date of April 17, 2024. The contract is a firm fixed-price agreement and is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the supply of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA). The $20,764.15 firm-fixed-price delivery order has an ultimate completion date of August 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA). The $2,651.84 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 10, 2023, with a performance completion date of August 11, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of the medication Xeljanz XR 11 mg tablets. The $1,663.88 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of October 28, 2021. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,940.91 firm-fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xeljanz XR 11 mg tablets. The $8,278.28 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,419.92 firm fixed-price delivery order is for the supply of Xeljanz 5 mg tablets, a prescription medication. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen, the prime contractor, does not have any set-aside designation for this award. This delivery order is placed against a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xeljanz XR 11 mg tablets. The $2,719.88 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,834.02, is for the delivery of the medication Xeljanz XR 11 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...